Last updated 9 months ago
A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis
123 patients around the world
Available in Colombia, Chile, Mexico, Argentina, United States
Boehringer Ingelheim
12Research sites
123Patients around the world
This study is for people with
Psoriasis
Generalized pustular psoriasis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
Av. Antartida Argentina entre calle 257 y camino Gral Belgrano S/N, Berazategui Buenos Aireshttps://www.facebook.com/fundacionrespirarsalud
Bulnes 1937, CABA, Buenos Aireswww.psoriahue.com/
Juan Domingo Perón 4190, Piso 1, Ciudad Autónoma de Buenos Aires, C1181ACH
Jerónimo Salguero 2142, CABA, Buenos Aires
Av. Córdoba 1184, CABA, Buenos Aires
Rua Mariz e Barros, nº 775 - Neurologia/2º andar - Tijuca - Rio de Janeiro/RJ - CEP 20270-901
Av. Manquehue Norte 2051 C, Vitacura, Metropolitana, 7640881dermacross.cl
Calle58 N° 52 C-2 - Medellín
Cra 12 No. 97-32, Of. 201-301-404, Bogotá
Av. Madero y Gonzalitos S/N, Mitras Centro, Monterrey, Nuevo Leónhttp://www.medicina.uanl.mx/hu/
Dr. Balmis 148, Col. Doctores, Del. Cuauhtémoc, Ciudad de México
StudyEffisayil™ 2
SponsorBoehringer Ingelheim
Study typeInterventional
Conditions
Generalized pustular psoriasis
Requirements
To 75 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT04399837
